CardioNet, Inc. - FORM 10-Q - XML - IDEA: XBRL DOCUMENT - May 10, 2012



Attached files
FileFilename
XML - IDEA: XBRL DOCUMENT - CardioNet, Inc.R6.htm
10-Q - 10-Q - CardioNet, Inc.a12-6367_110q.htm
XML - IDEA: XBRL DOCUMENT - CardioNet, Inc.R10.htm
XML - IDEA: XBRL DOCUMENT - CardioNet, Inc.R5.htm
XML - IDEA: XBRL DOCUMENT - CardioNet, Inc.R13.htm
XML - IDEA: XBRL DOCUMENT - CardioNet, Inc.R12.htm
XML - IDEA: XBRL DOCUMENT - CardioNet, Inc.R4.htm
XML - IDEA: XBRL DOCUMENT - CardioNet, Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - CardioNet, Inc.R3.htm
XML - IDEA: XBRL DOCUMENT - CardioNet, Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - CardioNet, Inc.R2.htm
XML - IDEA: XBRL DOCUMENT - CardioNet, Inc.R8.htm
EXCEL - IDEA: XBRL DOCUMENT - CardioNet, Inc.Financial_Report.xls
XML - IDEA: XBRL DOCUMENT - CardioNet, Inc.R9.htm
EX-32.1 - EX-32.1 - CardioNet, Inc.a12-6367_1ex32d1.htm
EX-31.2 - EX-31.2 - CardioNet, Inc.a12-6367_1ex31d2.htm
EX-31.1 - EX-31.1 - CardioNet, Inc.a12-6367_1ex31d1.htm
v2.4.0.6
Segment Information
3 Months Ended
Mar. 31, 2012
Segment Information  
Segment Information

 

6. Segment Information

 

ASC 280, Segment Reporting, establishes standards for reporting information regarding operating segments in annual financial statements. Operating segments are identified as components of an enterprise for which separate discrete financial information is available for evaluation by the chief operating decision-maker, or decision-making group in making decisions on how to allocate resources and assess performance.

 

The Company aggregates its operations into two reportable business segments, service and products. The patient service business segment’s principal focus is on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders, through its core Mobile Cardiac Outpatient Telemetry (MCOT), event and Holter services. The product business segment, which was developed through the Biotel acquisition in December 2010, focuses on the development, manufacturing, testing and marketing of medical devices and related software to medical companies, clinics and hospitals.

 

Summarized financial information concerning the Company’s reportable segments is shown in the following table:

 

 

 

Three Months Ended
March 31,

 

 

 

2012

 

2011

 

Revenues:

 

 

 

 

 

Patient service

 

$

23,663

 

$

30,432

 

Product

 

3,382

 

3,567

 

Total revenues

 

27,045

 

33,999

 

 

 

 

 

 

 

Loss before income taxes:

 

 

 

 

 

Patient service

 

(4,318

)

(1,553

)

Product

 

784

 

1

 

Total loss before income taxes

 

(3,534

)

(1,552

)

 

 

 

 

 

 

Depreciation and amortization:

 

 

 

 

 

Patient service

 

1,855

 

3,005

 

Product

 

165

 

277

 

Total depreciation and amortization

 

2,020

 

3,282

 

 

 

 

 

 

 

Capital expenditures:

 

 

 

 

 

Patient service

 

1,319

 

338

 

Product

 

53

 

58

 

Total capital expenditures

 

1,372

 

396

 

 

 

 

March 31,

 

December 31,

 

 

 

2012

 

2011

 

Total assets:

 

 

 

 

 

Patient service

 

78,402

 

82,451

 

Product

 

12,676

 

12,524

 

Total assets

 

91,078

 

94,975

 

 

User Contributions:

Comment about this document or add new information about this topic:

CAPTCHA



This web site and associated pages are not associated with, endorsed by, or sponsored by CardioNet, Inc. and has no official or unofficial affiliation with CardioNet, Inc.


Based on public records. Inadvertent errors are possible.
Faqs.org does not guarantee the accuracy or timeliness of any information on this site.  Use at your own risk. This website is not associated with the SEC

Some parts © 2013 Advameg, Inc.